Corpus Intelligence IC Memo — INSTITUTE FOR ORTHOPAEDIC SURGERY 2026-04-26 06:49 UTC
IC Memo — INSTITUTE FOR ORTHOPAEDIC SURGERY
Investment Committee Memorandum | OH | 12 beds | Grade C | EBITDA uplift $4.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

INSTITUTE FOR ORTHOPAEDIC SURGERY

CCN 360263 | ALLEN, OH | 12 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

INSTITUTE FOR ORTHOPAEDIC SURGERY is a 12-bed suburban community hospital in ALLEN, OH with $55.6M in net patient revenue and a 39.5% operating margin. The hospital serves a payer mix of 50.6% Medicare, 1.7% Medicaid, and 47.7% commercial.

Thesis: Turnaround. Our ML models identify $4.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 39.5% to 46.9% (+736bps).

Net Revenue HCRIS$55.6M
Current EBITDA COMPUTED$22.0M
Operating Margin COMPUTED39.5%
Occupancy HCRIS24.1%
Revenue / Bed COMPUTED$4.6M
Net-to-Gross HCRIS27.2%
Distress Probability ML48.9%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
23
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 39.5% places it above the state median. Among 23 size-comparable peers (6-24 beds), the median margin is -3.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (6-24), prioritizing same-state peers. 23 hospitals in the comp set.

HospitalStateBedsRevenueMargin
INSTITUTE FOR ORTHOPAEDIC SURG (Target)OH12$55.6M39.5%
THE SURGICAL HOSPITAL AT SOUTHOH24$166.6M-3.1%
WYANDOT MEMORIAL HOSPITALOH24$74.7M7.4%
MERCY HOSPITAL OF DEFIANCE LLOH23$50.4M-15.3%
OHIO VALLEY MEDICAL CENTEROH24$49.6M-6.3%
LAKE HEALTH BEACHWOOD MEDICAL OH24$49.2M-16.2%
SHELBY MEMORIAL HOSPITALOH20$40.2M13.0%
FOSTORIA COMMUNITY HOSPITALOH19$40.0M-3.4%
KINGS DAUGHTERS MED CENTER OHIOH10$36.1M31.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $4.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.2M+210bp18mo
Cost to Collect4.5%2.5%$1.1M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$677K+122bp9mo
Clean Claim Rate88.0%96.0%$36K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.2M
Cost to Collect
$1.1M
Denial Rate Reduction
$1.1M
A/R Days Reduction
$677K
Clean Claim Rate
$36K
Total EBITDA Uplift$4.1M
Current EBITDA$22.0M
+ RCM Uplift+$4.1M
Pro Forma EBITDA$26.1M
Current Margin39.5%
Pro Forma Margin46.9%
WC Released (1x)$2.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$33.8M$185.8M5.50x40.6%
Base (11x exit)10.0x11.0x$33.8M$215.4M6.37x44.8%
Bull Case9.0x11.0x$30.4M$239.9M7.89x51.1%
Bull (12x exit)9.0x12.0x$30.4M$270.7M8.90x54.8%
Bear Case11.0x10.0x$37.2M$154.4M4.15x33.0%
Bear (11x exit)11.0x11.0x$37.2M$181.9M4.89x37.4%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 24.1%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 23 hospitals with 6-24 beds
  • Same-state prioritization (n=25)
  • Comp margins: P25=-15.8% / P50=-3.4% / P75=15.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.